![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 413/12 | |
A61K 31/422 | |||
A61K 31/4245 | |||
C07D 417/12 | |||
A61P 3/00 | |||
A61P 3/04 | |||
A61P 3/10 |
(11) | Number of the document | 2852590 |
(13) | Kind of document | T |
(96) | European patent application number | 13727385.0 |
Date of filing the European patent application | 2013-04-25 | |
(97) | Date of publication of the European application | 2015-04-01 |
(45) | Date of publication and mention of the grant of the patent | 2017-02-01 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2013/053292 |
Date | 2013-04-25 |
(87) | Number | WO 2013/160873 |
Date | 2013-10-31 |
(30) | Number | Date | Country code |
201261639341 P | 2012-04-27 | US | |
PCT/CN2013/0727 | 2013-03-15 | WO | |
201361787695 P | 2013-03-15 | US |
(72) |
CHEN, Xin, US
DING, Yiping, CN
DUVADIE, Rohit, US
GAI, Yu, CN
HARRISON, Tyler, US
LIU, Qian, US
LARROW, Jay, US
MAO, Justin Yik Ching, US
PATEL, Sejal, US
YE, Jiong, CN
ZECRI, Frederic, US
ZHENG, Xuchun, CN
ZHENG, Rui, US
ZHOU, Yizong, CN
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS |
CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS |